Department of Physics and Biophysics, University of Varmia & Masuria in Olsztyn, 4 Oczapowskiego St., 10-719 Olsztyn, Poland
Mini Review
Enzymes and Drug Targets: Transition State Enzyme Inhibitors
Author(s): Viyanka Amoria*
Enzyme inhibitors or inactivators are a common class of drugs used to treat cancer, inflammatory, cardiovascular, metabolic, and infectious diseases. Models exist for every one of the six classes of catalysts, however inhibitors of hydrolases, transferases, and oxidoreductases prevail. At concentrations of 100 nanomolars or less, enzyme inhibitors or inactivators that eventually become drugs typically have a high selectivity for their targets and a high potency toward their targets. Thirteen ribozymes make up the human CYP4 family of enzymes, which typically catalyse the -oxidation of endogenous fatty acids and eicosanoids. 20-HETE, a crucial signalling eicosanoid involved in regulating vascular tone and kidney reabsorption, can be biosynthesized by several CYP4 enzymes. Additionally, the rare genetic disorders Refsum disease and X-ALD are characterized by the accumulation of particul.. View More»
DOI: 2572-5475- 08.06-120
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 